Back to search
Pseudohypoparathyroidism
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pseudohypoparathyroidism trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pseudohypoparathyroidism trials you may qualify forBackground: Parathyroid disorders are very common in the general population and include disorders of parathyroid excess, deficiency, or defects in parathyroid…
The goal of this observational study is to describe the natural history of imprinting disorders (IDs) according to their metabolic profile in all patients (adul…
We, the researchers, are following the natural history of Albright hereditary osteodystrophy. We have found that growth hormone deficiency is very common in pat…
The goal of this observational study is to create, manage and analyze a multicenter national database of patients affected by hypoparathyroidism or pseudohypopa…
The study evaluates the effect of theophylline in 100 subjects with Pseudohypoparathyroidism.
It is increasingly recognized that Pseudohypoparathyroidism type 1A (PHP1A) is associated with an increased risk of type 2 diabetes but the mechanism is unknown…
Pseudohypoparathyroidism is a genetic disorder with limited treatment options. Patients have early-onset obesity, short stature and increased risk of type 2 dia…
Pseudohypoparathyroidism is a genetic disorder with limited treatment options, characterized by early-onset obesity, short stature and resistance to multiple ho…